Bolt Biotherapeutics (BOLT) - Earnings growth in current year
The high scientific authority of Bolt Biotherapeutics (BOLT) is confirmed by this GURU.Markets platform chart, where the annual EPS change reached a metric value of -2.40. Bolt Biotherapeutics creates unique ISAC-conjugates to combat tumors, protecting its developments with strict patents. However, the immuno-oncology sector is seeing fierce competition with biotech behemoths striving for market dominance.
Analytical breakdowns and data insights for company boltbio.com (BOLT)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Debt to Equity Bolt Biotherapeutics|BOLT - Long-Term Debt to Equity|Current Liabilities to Capital Bolt Biotherapeutics, Inc.|BOLT - Company Debts|Debt to Book Capitalization Ratio Bolt Biotherapeutics|BOLT - Company Long-Term Liabilities|Amount of Current Liabilities Bolt Biotherapeutics|Intermediate Coverage Ratio boltbio.com
- earnings and market ratios statistics:
BOLT - Net Profit|Expected Profit Bolt Biotherapeutics|BOLT - P/E Multiple|Market Cap to Projected Earnings Bolt Biotherapeutics, Inc.|BOLT - Price/Earnings to Growth Ratio|Company Value to EBITDA Bolt Biotherapeutics|BOLT - Operating profit before deduction of amortization|Earnings per share for the last four quarters Bolt Biotherapeutics|BOLT - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months boltbio.com|BOLT - Earnings growth in current year|Expected net earnings per share growth next year Bolt Biotherapeutics
- sales volume and revenue information:
Basic company analysis:Bolt Bio, BOLT
Bolt Biotherapeutics is developing the Boltbody immuno-oncology platform with support from Pfizer and under strict FDA oversight. This indicator captures the percentage deviation of current earnings per share from the value of the same period last year. It allows for an assessment of capital management efficiency and business scaling rates. The metric's trend confirms the company's financial stability within a stringent regulatory framework. By analyzing the comparable year-over-year earnings per share growth rate, an investor determines the issuer's development phase.
Key competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|ADPT: Earnings per share growth in current year|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth rate in current year auriniapharma.com (AUPH)|Earnings per share growth in current year BioCryst Pharmaceuticals|Earnings per share growth in current year VERA|Net earnings per share growth this year DNTH (Dianthus Pharma)|Net earnings per one share growth for the current year PHVS|AbCellera Biologics - Net earnings per share growth this year|Earnings per share increase in current year TRML|Precigen - Earnings growth in current year|PHAR: Earnings per share growth in current year|NKTR: Earnings growth in current year|UPB - Expected net earnings per share growth this year|Earnings per share growth in current year Zenas Biopharma Inc|Earnings per share growth rate in current year immunome.com IMNM|Net earnings per share growth this year GOSS (Gossamer Bio)|Net earnings per one share growth for the current year KALV|Earnings growth in current year SEPN (Septerna Corp)|Earnings per share increase in current year PVLA|Savara Inc. - Earnings growth in current year|Earnings per share growth rate in current year rigel.com|AnaptysBio (ANAB) - Earnings per share growth in current year|Astria Therapeutics Inc - Earnings per share increase in current year|ENGN (enGene Bio) - Earnings growth in current year|Earnings growth in current year RAPT Therapeutics Inc.|Earnings per share growth in current year Aerovate Therapeutics Inc (JBIO)|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (Kyverna Therapeutics, Inc.)|Tiziana Life Sciences Ltd. (TLSA) - Earnings per share growth rate in current year|CABA: Net earnings per share growth this year|VTYX - Earnings growth in current year|THTX (Theratechnologies Inc.) - Net earnings per share growth this year|AVTX: Net earnings per one share growth for the current year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|Agenus, Inc. (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|Net earnings per share growth this year Zura Bio Ltd ZURA|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Expected net earnings per share growth this year Adagene Inc (ADAG)|Ikena Oncology, Inc. - Earnings growth in current year|STTK: Earnings per share growth in current year|equilliumbio.com (EQ) - Earnings per share growth in current year|Earnings per share growth rate in current year Connect Biopharma Holdings Limited (CNTB)|Earnings per share growth in current year Immunic Therapeutics|Earnings per share growth in current year ATRA|Net earnings per share growth this year IFRX (InflaRx N.V.)|Net earnings per one share growth for the current year XFOR|Earnings per share growth in current year Adicet Bio, Inc. ACET|CELU (Celularity Inc) - Earnings per share trend in current year|INmune Bio, Inc. - Earnings growth in current year|Earnings per share increase in current year BRNS (barinthusbio.com)|KZR: Earnings growth in current year|SAB Biotherapeutics Inc. (SABS) - Earnings growth in current year|Earnings per share growth in current year Akari Therapeutics plc|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio Inc. (QTTB)|Net earnings per share growth this year geovax.com GOVX|Earnings growth in current year EDSA (Edesa Biotech)|Earnings growth in current year iBio Inc IBIO|CARM: Net earnings per share growth this year|Earnings per share increase in current year XTLB (XTL Bio)|HCWB: Earnings growth in current year|APVO - Expected net earnings per share growth this year|Earnings per share growth in current year AIM ImmunoTech Inc.|Net earnings per share growth this year Aditxt Corp (ADTX)|Earnings per share growth in current year GRI Bio Corp (GRI)|Net earnings per share growth this year XORTX Corp XRTX|Vyome Holdings Inc - Net earnings per share growth this year|Earnings growth in current year revbiosciences.com REVB|INDP - Earnings per share growth in current year|SCNI (Scinai Immunotherapeutics Ltd) - Earnings per share growth this year|CALI: Earnings growth in current year|Earnings per share growth rate in current year Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Earnings growth in current year|Earnings per share growth in current year HOOK|Earnings per share growth in current year IGM Biosciences, Inc. (IGMS)|ITOS - Earnings per share growth rate in current year|Earnings per share growth in current year Ocean Bio OCEA|TC BioPharm Ltd - Earnings per share growth in current year|THRD: Net earnings per share growth this year
